staypuff
13時間前
With the price going down daily I was thinking about options to try and get some type of answer or response. People claimed to have called Glickman and that has got us nowhere, we have no CC calls anymore to raise questions, we get no PRs anymore, and the idea has been floated about legal action but that appears to be going nowhere. Another idea would be to have a formal letter written and directed specifically to the Board and Audit Committee of NXPL raising our questions, concerns, etc to see if we can get some type of action or response. If nothing is received to keep sending until we do. I am not going to be the ideal person to draft such a document but wanted to raise that idea to the group.
garrox
3日前
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNOVEMBER 18, 2024 8:00AM EST Download as PDFOPKO Healthcare's Veterinary Care Products to be Introduced at Asia's Largest Health and Nutrition TradeshowCompany Invited to Present at Special Event Hosted by U.S. Consulate General During the ExpoCOCONUT GROVE, Fla., Nov. 18, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-commerce provider, today announced that it is participating in the 2024 China International Natural Health & Nutrition Expo (NHNE), Asia's largest exhibition focused on the sales and marketing of health, nutrition and dietary supplement products, as the Company continues to ramp-up sales and promotional activities in China.Held at the Wuhan International Expo Center from November 20thto the 22nd, the China International Natural Health & Nutrition Expo is the premier exhibition focused on health, nutrition and dietary supplements. The bi-annual event is the largest of its kind in Asia with 1,200 suppliers from more than 30 countries and regions, attracting as many as 120,000 omnichannel buyers. At the event, an expanded array of products from OPKO Health Europe, a unit of OPKO Health, Inc. (NASDAQ: OPK) (OPKO), including an initial selection of veterinary and animal care products will be on display for attendees.Additionally, NextPlat has also been invited by the U.S. Consulate General in Wuhan to present OPKO products during the NHNE expo to a specially selected group of Chinese buyers interested in U.S. healthcare products."Over the past few weeks, with the support of our in-country marketing and sales partner, we have seen demand for our OPKO products significantly increase as we ramp-up online and offline promotional activity. Through participation in NHNE, we have access to thousands of potential new retail and distribution partners making it the ideal venue for us to introduce OPKO's animal health products," said David Phipps, President of NextPlat and CEO of Global Operations. "Based upon strong interest in our initial product offerings, through increased inventory, and the introduction of new products for health, wellness and pets, we are confident in the significant sales potential we see in China."As announced earlier this year, the Company has begun the sales of OPKO products in China and supported by a new in-country marketing partner, has recently engaged Chinese social media influencers and conducted experiential marketing programs. The Company is currently in the process of launching new online OPKO storefronts on leading digital sites in China including WeChat which has over 1.3 billion monthly users, and on JD.com, China's second largest e-commerce platform which attracts in excess of 560 million users annually. Additionally, the Company is seeking to secure physical distribution of OPKO products into major retail chains, pharmacies and grocery stores during 2025.OPKO is a global diversified diagnostic and pharmaceutical healthcare company with over 5,500 employees spanning nine countries. The distribution agreement with OPKO's European division represents the first relationship resulting from the Company's Florida E-commerce Development program which includes a merchant sourcing agreement with Alibaba's Tmall Global designed to provide American businesses with easy access to the Chinese consumer market.About NextPlat CorpNextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the Company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care LLC.Forward-Looking Statements
MrMike241
6日前
Good luck with your new shares Gedi! I have cash but I'm not feeling like I can average here. I agree that insiders are underwater and I hope that they are not happy about that!! What confuses me is that NXPL management doesn't even try to share a vision that would attract investors, and reverse their loss. I know about the PR's for NXPL China sales and other business segments, but what happened to expanding the RXMD business with locations, technology products, healthcare products (OK, the vitamins are a bit hopeful, if they can compete), ...anything innovative other than reselling drugs. I get the feeling that RXMD is set aside and will go stagnant as focus is an overall regret about investing in a healthcare company (that is my take from Flaker's visit today). If that's true, they should just finance a profitable sale back to Armen, or better, Shital. I know that will never happen, but my hope has degraded to wishing. I invested in and I miss the communication that came from Shital! Even Armen was hopeful, until he made a bad deal for himself and shareholders alike. I believe Armen had good intentions toward shareholders and he lost everything because he wasn't smart enough to make a solid deal with contingencies.
Charlie needs to communicate if he is honest about wanting to do right by former RXMD shareholders, and if he is serious about wanting to reverse his loss on the shares that he owns today, vs. the shares that he'd issue himself after another rs. That's my worst fear here. Is that fear justified? Trading below $1 it at least seems possible.
When I did it in June, I felt bad about realizing a 60% loss on 50% of my investment. Now, I'm wondering if I should have closed my position. My position was large. My loss is large. OK, I've said my thing, I won't keep repeating it. I hope that I'm given a reason to resume posting positive content here!! But I can't make it up, it needs to be based on communication from inside.
IMO
Good Luck NXPL Shareholders!
$NXPL